throbber
Curriculum Vitae. Professor Stanley (Bob ) Davis
`
`Professional Address:
`
`Institute of Pharmaceutical Sciences, University of
`Nottingham, University Park, Nottingham, NG7 2RD,
`UK
`
`Home Address:
`
`19 Cavendish Crescent North, The Park, Nottingham,
`NG7 1BA, UK
`
`Summary
`(cid:120) Professor SS (Bob) Davis obtained his Bachelors degree in Pharmacy from the
`School of Pharmacy at the University of London in 1964. He remained at the
`same University to study for a PhD in colloid science (1967). In 1966 he was
`appointed Assistant Lecturer in Pharmaceutics and then to Lecturer in 1967.
`He was awarded his Doctor of Science degree (higher doctorate) in 1982. In
`1968 he was awarded a one year Fulbright Scholarship to undertake
`postdoctoral studies with Professor Takeru Higuchi at the University of
`Kansas, USA in the field of solution thermodynamics. In 1970 he moved to
`the University of Aston in Birmingham as Senior Lecturer and Head of the
`Pharmaceutics section. Here, he built up an active research group in drug
`delivery systems.
`
`(cid:120) Professor Davis took the position of Lord Trent Professor of Pharmacy at
`Nottingham in 1975, where he ran a large research group, studying novel drug
`delivery systems. Topics of research have included drug targeting (with
`particular emphasis on colloidal carriers), transmucosal delivery, oral and
`parenteral systems for controlled release and product evaluation through
`gamma scintigraphy. He became an emeritus professor in 2003.
`
`(cid:120) He has published over 750 papers and is co-editor of 7 books. He is the named
`inventor on numerous patents dealing with drug delivery. He is the Co-
`founder of three pharmaceutical companies; CDD (co-ordinated drug delivery)
`(now Vectura Ltd); Danbiosyst (UK) Ltd (sold to West Pharmaceutical
`Services and then to Archimedes ) and Pharmaceutical Profiles Ltd. He has
`acted as a Consultant to various pharmaceutical companies and has worked as
`a visiting Scientist in the USA at Syntex, Allergen, and Alza.
`
`(cid:120) He has acted as a consultant to many major pharmaceutical companies in the
`USA, Europe and Japan.
`
`(cid:120) He has served on numerous Committees and Panels, to include those of the
`British and European Pharmacopoeias, the United Kingdom Medicines
`Commission, The Science & Engineering Research Council, UK.
`
`(cid:120) Awards received include The Science Award (The British Pharmaceutical
`Conference, 1971), The Scheele Award (Swedish Pharmaceutical Association,
`1985), The Maurice-Marie Janot Award (APGI, France, 1986) (The Harrison
`
`1 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`Memorial Medal, Royal Pharmaceutical Society, 2000), The Eurand Career
`Achievement Award for Outstanding Research in Oral Drug Delivery (The
`Controlled Release Society,
`2003) The Host Madsen Medal
`(FIP)(International Pharmaceutical Federation)(2005).
`In 2008 he was
`awarded an honorary doctor of science degree from London University.
`
`(cid:120)
`
`In 2010 he was made a Fellow of the Controlled Release Society.
`
`(cid:120) He is a Fellow of the Royal Society of Chemistry, The Royal Pharmaceutical
`Society and the American Association of Pharmaceutical Sciences.
`
`(cid:120)
`
`In 2013 we was made a Fellow of University College, London,
`
`(cid:120) Professor Davis has served on the editorial boards of various scientific
`journals to include Pharmaceutical Research, Advanced Drug Delivery
`Reviews, International Journal of Pharmaceutics, Biomaterials, Journal of
`Pharmacy and Pharmacology, Critical Reviews in Therapeutic Drug Carriers,
`Journal of Drug Targeting, American Journal of Dug Delivery, Pharmaceutical
`Development Technology, Journal of Microencapsulation, and Journal of
`Controlled Release
`
`(cid:120) His non-scientific interests include skiing, sailing and art.
`
`2 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`3 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`SS Davis - Litigation/ Court appearances/ Depositions etc.
`
`2005 Canada
`Tamsulosin ER-Deposition (2005) Boehringer Ingelheim and Yamanouchi v. Novopharm
`and the Minister of Health (Canada)
`
`2006, 2007 USA
`Biaxin-Depositions (2) (2006,2007) Abbott v. Sandoz and others
`
`2008 UK
`Oxycodone-ER-Court Testimony (2008) Ratiopharm and Sandoz v. Napp Laboratories
`
`2010 Canada
`Tamsulosin ER -Depositions (2) (2010) Boehringer Ingelheim and Astellas v. Apotex and
`the Minister of Health (Canada),
`Boehringer Ingelheim and Astellas v. Sandoz and the Minister of Health (Canada)
`
`2010 USA
`Deposition and Testimony in Court (2010)
`United States District Court-Delaware 09-MD-2118SLR
`Eurand, Cephalon, Anesta v. Mylan, Barr and others
`
`2010, 2011 USA
`Deposition and Testimony in Court (2010/2011)
`United States District Court New Jersey, 07-cv-5041-SDW-MCA
`King Pharmaceuticals, Elan v. Actavis Inc.
`
`2011 USA
`Deposition and Testimony in Court 2011
`United States District Court-Delaware 09-511-GMS
`Allergan and others v. Watson Laboratories and others
`
`2011, 2012 USA
`Depositions (2) 2011, 2012
`United States District Court-New Jersey, No. 2:10-cv-03561-WJM-MF
`Roche Palo Alto Llc, Gilead Palo Alto, Inc. and Gilead Sciences, Inc., V. Lupin
`Pharmaceuticals, Inc. and Lupin Ltd.,
`
`2012 USA
`Deposition 2012
`United States District Court-New Jersey, No.07-cv-12999 (SRC) (CLW)
`Tyco Healthcare Group LP and Mallinckrodt Inc. V. Mutual Pharmaceutical Company,
`Inc. and United Research Laboratories, Inc.
`
`4 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`2012, 2013 USA
`Depositions (2) and Court Testimony 2012, 2013
`United States District Court-New Jersey, Civ.A.No2:10-03561 (ES) (CLW)
`Roche Palo Alto LLC., Gilead Palo Alto, Inc. and Gilead Sciences, Inc., V. Lupin
`Pharmaceuticals Inc. and Lupin Ltd.
`
`2013, 2014 USA
`Deposition (2013) and Court Testimony 2014
`United States District Court-New Jersey, Civ.A. No.11-cv-5989 and 6936, No.12-cv-2474
`Warner Chilcott Company LLC V. Watson Laboratories, Teva Pharmaceuticals USA ,
`INC and Ranbaxy Inc.
`
`2014 USA
`Deposition and Court Testimony
`United States District Court, Delaware, Civ.A. No. 13-1015-SLR
`Fresenius Kabi USA, LLC V. Watson Laboratories and Actavis, INC
`
`2014 USA
`Deposition
`United States District Court, Delaware, Civ.A. No. 12-1104-GMS
`Salix Pharmaceuticals INC and Dr .Falk Pharma GmbH V. Lupin Pharmaceuticals, INC. and
`Lupin Ltd.,
`
`2014 USA
`Deposition
`United States District Court-New Jersey, Civ.A. No.2:13-cv-04507-CCC-MF
`Janssen Pharmaceuticals INC. and Grunenthal GmbH. V. Actavis INC.
`
`2015 USA
`Deposition and Court Testimony Civ.A.12-CIV-8060-TPG etc.
`United States District Court, Southern Division of New York
`Endo Pharmaceuticals INC and Grunenthal GmbH V. Teva Pharmaceuticals USA INC ,
`Impax and ThoRx Laboratories INC, Actavis INC.
`
`5 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`
`
`PUBLICATIONS - STANLEY S DAVIS
`CHRONOLOGICAL LISTING
`
`PhD (1967): The Effect of Emulsifier Concentration on the Rheological and Physical Properties of
`some Emulsion Systems (London University)
`
`DSc (1981): The Physicochemical Properties of Pharmaceutical Systems (London University)
`
`
`
`1. SHOTTON, E. and DAVIS, S.S. "The influence of emulsifier concentration on the creaming of an
`emulsion system". J. Pharm. Pharmac. 19 155s-167s (1967).
`
`2.
`
`3.
`
`4.
`
`5.
`
`SHOTTON, E. and DAVIS, S.S. "The use of the Coulter Counter for the particle size analysis of
`some emulsion systems". J. Pharm. Pharmac. 20 430-438 (1968).
`
`SHOTTON, E. and DAVIS, S.S. "The influence of emulsifier concentration on the rheological
`properties of an oil in water emulsion stabilised by an anionic soap".
`J. Pharm. Pharmac. 20 439-449 (1968).
`
`SHOTTON, E. and DAVIS, S.S. "The effect of emulsifier concentration on the rheological
`properties of acacia emulsions". J. Pharm. Pharmac. 20 780-789 (1968).
`
`SHOTTON, E. and DAVIS, S.S. "A note on the stability of emulsions at high dilution". J. Pharm.
`Pharmac. 20 825-829 (1968).
`
`6. DAVIS, S.S., DEER, J.J. and WARBURTON, B. "A concentric cylinder air-turbine viscometer". J.
`Sci. Instrum. Series 232, 1 933-936 (1968).
`
`7. DAVIS, S.S. and WARBURTON, B. "A note on the evaluation of results from Creep tests using a
`Computer". J. Pharm. Pharmac. 20 836-839 (1968).
`
`8. DAVIS, S.S., SHOTTON, E. and WARBURTON, B. "Some limitations of continuous shear
`methods for the study of pharmaceutical semi-solids".
`J. Pharm. Pharmac. 20 157s-167s (1968).
`
`9. DAVIS, S.S. "Modification to a variable shear stress air turbine viscometer". J. Sci. Instrum. Series
`2 2 102-103 (1969).
`
`10. DAVIS, S.S. and DIPPY, J.E. "The Rheological Properties of sputum". Biorheology 6 11-21
`(1969).
`
`6 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`11. DAVIS, S.S. "Viscoelastic properties of pharmaceutical semi-solids, I: Ointment Bases". J.
`Pharm. Sci. 58 412-418 (1969).
`
`12. DAVIS, S.S. "Viscoelastic properties of pharmaceutical semi-solids, II: Creams". J. Pharm.
`Sci. 58 418-421 (1969).
`
`13. HIGUCHI, T., RICHARDS, J.H., DAVIS, S.S., KAMADA, A., HOU, J.P., NAKANO, M.,
`NAKANO, N.I. and PITMAN, I.H. "Solvency and hydrogen bonding interactions in
`non-aqueous systems". J. Pharm. Sci. 58 661-671 (1969).
`
`14. WARBURTON, B. and DAVIS, S.S. "The oscillatory testing of pharmaceutical semi-solids
`using a transfer function analyser". Rheol. Acta 8 205-214 (1969).
`
`15. DIPPY, J.E. and DAVIS, S.S. "Rheological assessment of mucolytic agents on sputum of
`chronic bronchitics". Thorax 24 707-713 (1969).
`
`16. DAVIS, S.S. "The rheological evaluation of semi-solid materials". American Perfumer and
`Cosmetics 85 45-49 (1970).
`
`17. DAVIS, S.S. "Molar attraction constants applied
`Experientia 26 671-672 (1970).
`
`to structure activity relationships".
`
`18. HIGUCHI, T. and DAVIS, S.S. "Thermodynamic analysis of structure activity relationships of
`drugs. Prediction of optimal structure". J. Pharm. Sci. 59 1376-1383 (1970).
`
`19. DAVIS, S.S., WARBURTON, B. and DIPPY, J.E. "Chemical balance as a rheometer for
`biological fluids". J. Pharm. Sci. 59 1764-1769 (1970).
`
`20. DAVIS, S.S. "Saliva is Viscoelastic". Experientia 26 1298-1300 (1970).
`
`21. DAVIS, S.S."The rheological properties of saliva". Rheol. Acta 10 28-35(1971).
`
`22. DAVIS, S.S. "The properties of emulsions stabilised by mixtures of anionic surfactant and
`anionic polyelectrolyte". J. Colloid Interface Sci. 35 665-674 (1971).
`
`23. SHOTTON, E., WIBBERLEY, K., WARBURTON, B., DAVIS, S.S. and FINLEY, P. "A
`versatile surface rheometer". Rheol. Acta 10 142-152 (1971).
`
`24. KISLALIOGLU, S., SHOTTON, E., DAVIS, S.S. and WARBURTON, B. "Rheological
`properties of thin gelatin films". Rheol. Acta 10 158-162 (1971).
`
`25. DAVIS, S.S. "Deaggregation of acacia emulsions". Kolloid Z. 246 600-605 (1971).
`
`26. DAVIS, S.S. "Viscoelastic properties of pharmaceutical semi-solids, III. Non-destructive
`oscillatory testing". J. Pharm. Sci. 60 1351-1356 (1971)
`
`7 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`27. DAVIS, S.S. "Viscoelastic properties of pharmaceutical semi-solids, IV. Destructive oscillatory
`tests". J. Pharm. Sci. 60 1356-1360 (1971).
`
`28. DAVIS, S.S. "Hydrophobic bonding in soap stabilised emulsions". J. Pharm. Pharmac. 23
`161s-169s (1971).
`
`29. DAVIS, S.S. "Rheological examination of sputum and saliva and the effect of drugs". In "Rheology
`of Biological Systems", Editors, Gabelnick, H. and Litt,
`M., Charles C. Thomas and Co., Springfield III. Chap. 7 pp158-194 (1973).
`
`30. DAVIS, S.S. "Scientific principles in the design of drug dosage formulations".
`Brit. Med. J. 1 102-106 (1972).
`
`31. DAVIS, S.S. "Calibration of the rheogoniometer with Newtonian fluids". Rheol. Acta 11 199-202
`(1972).
`
`32. RYTTING, J.H., DAVIS, S.S. and HIGUCHI, T. "Suggested thermodynamic standard state for
`comparing drug molecules in structure activity studies". J. Pharm. Sci. 61 816-818 (1972).
`
`33. DAVIS, S.S. "Rheological properties of semi-solid foodstuffs". J. Texture Studies 4 15-40 (1973).
`
`34. DAVIS, S.S., HIGUCHI, T. and RYTTING, J.H. "Determination of thermodynamics of the
`methylene group in solutions of drug molecules". J. Pharm. Pharmac. 24 30P-46P (1972).
`
`35. ADAMS, I., DAVIS, S.S. and KERSHAW, R. "Formulation of a sterile surgical lubricant". J.
`Pharm. Pharmac. 24 178P (1972).
`
`36. DAVIS, S.S. and SMITH, A. "Effect of disperse phase on the stability of emulsion droplets". J.
`Pharm. Pharmac. 24 155-156P (1972).
`
`37. DAVIS, S.S. and MUKHAYER, G.I. "Interaction of large organic ions. Effects of molecular
`structure". J. Pharm. Pharmac. 24 129-130P (1972).
`
`38. DAVIS, S.S. and KHANDERIA, M.S. "Viscoelastic properties of pharmaceutical semi-solids. V.
`Characterisation of the Plastibases for bioavailability studies".
`J. Pharm. Pharmac. 24 176-177P (1972).
`
`39. DAVIS, S.S. "Determination of the thermodynamics of the methyl group in solutions of drug
`molecules". J. Pharm. Pharmac. 25 1-12 (1973).
`
`40. DAVIS, S.S. "Techniques for the measurement of the rheological properties of sputum". Bull.
`Physiopath. Resp. 9 47-90 (1973).
`
`8 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`41. DAVIS, S.S. and SMITH, A. "The interpretation of droplet coalescence data using the log
`normal distribution". Kolloid Z. 251 337-342 (1973).
`
`42. DAVIS, S.S. "Scientific principles in drug dosage design". Pharmaceutical Journal 210 205-208
`(1973).
`
`43. DAVIS, S.S. "Is Pharmaceutical Rheology Dead?". Pharm. Acta Helv. 49 161-168 (1974).
`
`44. DAVIS, S.S. "Use of substituent constants in structure-activity relations and the importance of
`the choice of standard state". J. Pharm. Pharmac. 25 293-296 (1973).
`
`45. DAVIS, S.S., HIGUCHI,T. and RYTTING, J.H. "Determination of thermodynamics of
`functional groups in solutions of drug molecules. A critical evaluation of the thermodynamic
`properties of organic compounds using the "Group Contribution" approach. Its application to
`solution behaviour drug absorption and distribution and structure-activity relationships".
`Advances in Pharmaceutical Sciences Vol. 4 73-261 (1974).
`
`46. ADAMS, I. and DAVIS, S.S. "Formulation and sterilisation of a surgical lubricant gel based on
`carboxypolymethylene". J. Pharm. Pharmac. 25 640-646 (1973).
`
`47. ECCLESTON, G., DAVIS, S.S. and BARRY, B.W. "Correlation of viscoelastic functions for
`pharmaceutical semisolids: comparison of creep and oscillatory tests for oil-in-water creams
`stabilised by mixed emulsifiers". J. Pharm. Sci. 62 1954-1961 (1973).
`
`48. DAVIS, S.S. "Determination of the thermodynamics of halogen groups in solutions of drug
`molecules". J. Pharm. Pharmac. 25 769-778 (1973).
`
`49. DAVIS, S.S. "The biological availability of drugs". Medicine Today, 7 49-59 (1973).
`
`50. DAVIS, S.S. "The determination of the thermodynamics of hydroxyl and carboxyl in solutions
`of drug molecules". J. Pharm. Pharmac. 25 983-992 (1973).
`
`51. SMITH, A. and DAVIS, S.S. "The role of molecular diffusion in the bulk stability of o/w
`hydrocarbon emulsions". J. Pharm. Pharmac. 25 117P (1973)
`
`52. WILLIAMS, M.E., KENDALL, M.J., DAVIS, S.S., POXON, R. and MITCHARD, J.
`"Availability of methaqualone from commercial preparations - in vitro and in vivo studies in
`man". Brit. J. Clin. Pharmacol. 1 99-105 (1974).
`
`53. DAVIS, S.S. "Pharmaceutical aspects of intravenous fat emulsions". J. Hosp. Pharm.
`Supplement 149-160, 165-170 (1974).
`
`9 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`54. WILLIAMS, M.E., KENDALL, M.J., DAVIS, S.S., POXON, R. and MITCHARD, M. "The
`influence of diphenyhydramine on the absorption of methaqualone in man". Brit. J. Clin.
`Pharmacol. 1 259-264 (1974).
`
`55. DAVIS, S.S. and SMITH, A. "The influence of disperse phase on the stability of oil-in-water
`emulsions". In Emulsions in Theory and Practice, Ed. A.L. Smith, Chapter 19, p325-346, Academic
`Press, London, 1976.
`
`56. MUKHAYER, G.I., DAVIS, S.S. and TOMLINSON, E. "Automated conductimetric
`titrimeter. Use in studying ionic solute-solute interactions". J. Pharm. Sci. 64 147-151 (1975).
`
`57. DAVIS, S.S. and SMITH, A. "The stability of hydrocarbon oil droplets at the surfactant/oil
`interface". J. Colloid and Polymer Science, 254 82-98 (1976).
`
`58. DAVIS, S.S. "The effect of mutual solubility on the distribution of the methylene group between
`different organic solvents and water". Separation Science 10 1-20 (1975).
`
`59. DAVIS, S.S. and ELSON, G. "Determination of partition coefficient data using the AKUFVE
`method". J. Pharm. Pharmac. 26 Suppl. 90P (1974).
`
`60. DAVIS, S.S., INGLIS, A., McNEIL, D. and SCOBIE, S. "A mucin model for the in vitro
`evaluation of mucolytic agents". J. Pharm. Pharmac. 26 Suppl. 64P (1974).
`
`61. GUVELI, D., DAVIS, S.S. and KAYES, J.B. "Viscometric studies on surface active agent solutions
`and the examination of hydrophobic interactions". J. Pharm. Pharmac. 26 Suppl. 127-128P (1974).
`
`62. DAVIS, S.S., SCOBIE, S. and INGLIS, A. "The effect of sulphydryl compounds and cross-linking
`agents on the viscous and viscoelastic properties of mucus". Biorheology 13 225-232 (1975).
`
`63. CALDER, G., DAVIS, S.S., DEWELL, J.V., PHESEY, D.A. and VAN REST, D.J. "Pharmacy and
`Medicine - an examination of the professional interface". Pharm. J. 214 280-282 (1975).
`
`64. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite charge. I.
`The stoichiometry of the interactions of sodium dodecyl sulfate with benzyltriphenylphosphonium
`chloride". J. Colloid Interface Sci. 53 224-234 (1975).
`
`65. DAVIS, S.S. "The Emulsion, Obsolete Dosage Form or Novel Drug Delivery System?". J. Clin.
`Pharmacy 1 11-27 (1976).
`
`10 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`66. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite
`charge. II. The effect of ionic strength, temperature and urea on the interaction between sodium
`dodecyl sulfate and benzyltriphenyl phosphonium chloride". J. Colloid Interface Sci. 56
`350-359 (1976).
`
`67. DAVIS, S.S., ELSON, G., TOMLINSON, E., HARRISON, G. and DEARDEN, J. "The rapid
`determination of partition coefficient data using a continuous solvent extraction system
`(AKUFVE)". Chemistry and Industry, 21 Aug. 667-683 (1976).
`
`68. DAVIS, S.S. "The solubility of liquids in liquids: water-2-butanone". An assignment unit for an
`example booklet published by IUPAC Subcommission V61 on equilibrium data. Solubility Data
`Project. Pergamon Press, Oxford, 1976.
`
`69. BYRON, P., DAVIS, S.S., BUBB, M.D. and COOPER, P. "Pharmaceutical implications of
`particle growth at high relative humidities". Pesticide Sci. 8 521-526 (1977).
`
`70. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite
`charge. III. The effect of molecular structure on the interaction between sodium alkyl sulfate
`and phosphonium salts. The alkyl chain". J. Colloid Interface Sci. 59 350-359 (1977).
`
`71. DAVIS, S.S. "Recent developments in dosage form design". Drug Dev. Commun. 2 151-169
`(1976).
`
`72. TOMLINSON, E. and DAVIS, S.S. "Increased uptake of an anionic drug by mucous membrane
`upon formation of ion-association species with quaternary ammonium salts". J. Pharm.
`Pharmac. 27 Suppl. 60P (1976).
`
`73. DAVIS, S.S., BURBAGE, A.S. and PUREWAL, T.S. "Particle size analysis of multiple
`emulsions". J. Pharm. Pharmac. 27 Suppl. 60P (1976).
`
`74. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite
`charge. IV. The effect of molecular structure. The interaction between sodium dodecyl sulfate
`and substituted benzyltriphenyl phosphonium chlorides".
`J. Colloid Interface Sci. 61 582-589 (1977).
`
`75. DAVIS, S.S. and DEVERELL, L.C. "Rheological factors in mucociliary clearance. The
`assessment of mucotropic agents using an in vitro model". In Modern Problems in Paediatrics,
`Editors: F. Falkener et al, Karger, Basle, 207-217 (1977).
`
`76. DAVIS, S.S., PUREWAL, T., BUSCALL, R., SMITH, A. and CHOUDHURY, K. "The
`stability of fluorocarbon emulsions. The effect of the chemical nature of the oil phase". In
`Recent Advances in Colloid and Interface Science, Vol. II, Kerker, M., Editor, pp265-288.
`Academic Press (1976).
`
`11 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`77. KERTES, A.S., BATTINO, R., CLEVER, H.L., DAVIS, S.S., GERRARD, W., SIGNWORTH,
`G.K. and YOUNG, C.L. "Solubility Data Project. Compilation and critical evaluation of solubility
`data in all physical systems". Proceedings 5th International CODATA conference, Boulder,
`Colorado, 1976, p74-82.
`
`78. DAVIS, S.S., KHANDERIA, M.S., ADAMS, I., COLLEY, I.R., CAMMACK, J. and SANFORD,
`P. "The effect of gamma radiation on the rheological properties of pharmaceutical semi-solids". J.
`Texture Studies 8 61-80 (1977).
`
`79. DAVIS, S.S. and KHANDERIA, M. "The influence of the rheological properties of the vehicle on
`the release of drugs from semi-solid ointments". Proceedings 1st International Conference on
`Pharmaceutica Technology, Vol. I, 30-47 (1977). APGI, Paris.
`
`80. DAVIS, S.S. and BURBAGE, A.S. "Electron micrography of water-in-oil-in-water emulsions". J.
`Colloid Interface Sci. 62 361-363 (1977).
`
`81. TOMLINSON, E., BROWN, M.R.W. and DAVIS, S.S. "Effect of colloidal association on the
`measured activity of alkylbenzyldimethylammonium chlorides against Pseudomonas aeruginosa".
`J. Med. Chem. 20 1277-1282 (1977).
`
`82. TOMLINSON, E. and DAVIS, S.S. "Ion pairs and acceptor-donor complexes as models for drug
`receptor interactions". In Biological Activity and Chemical Structure, Editor J.A. Keverling
`Buisman, Elsevier, Amsterdam (1978).
`
`size analysis of multiple emulsions
`"Particle
`83. DAVIS, S.S. and BURBAGE, A.S.
`(water-in-oil-in-water)". In Particle Size Analysis, Edited by M.J. Groves, pp395-410, Heyden,
`London, 1978.
`
`84. DAVIS, S.S. "Physicochemical studies on aerosol solutions for drug delivery. I. Water-Propylene
`Glycol Systems". Int. J. Pharmaceut. 1 71-83 (1978).
`
`85. DAVIS, S.S., ELSON, G. and WHITMORE, J. "Physicochemical studies on aerosol solutions for
`drug delivery. II. Water-Propylene Glycol-Ethanol Systems". Int. J. Pharmaceut. 1 85-93 (1978).
`
`86. VINCENT, B. and DAVIS, S.S. "Emulsions". In Colloid Science, Vol. 3, Specialist Periodical
`Reports, Editor Everett, D.H., The Chemical Society, London, 193-229 (1979).
`
`87. BUSCALL, R., DAVIS, S.S. and POTTS, D.C. "The effect of long chain alkanes on the stability of
`oil-in-water emulsions. The significance of Ostwald ripening". Colloid and Polymer Science 257
`636-644 (1979).
`
`12 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`88. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite
`charge. V. The effect of substituted ureas on the interaction between sodium dodecyl sulfate and
`benzyltriphenylphosphonium chloride"". J. Colloid Interface Sci. 65 210-215 (1978).
`
`89. MUKHAYER, G.I. and DAVIS, S.S. "Interactions between large organic ions of opposite
`charge. VI. Coacervation
`in mixtures of
`sodium dodecyl
`sulfate and benzyl
`triphenylphosphonium chloride". J. Colloid Interface Sci. 66 110-117 (1978).
`
`90. TOMLINSON, E. and DAVIS, S.S. "Interactions between large organic ions of opposite and
`unequal charge. I.
` Complexation between alkylbenzyldimethyl ammonium chlorides,
`bischromones and indigo carmine". J. Colloid Interface Sci. 66 335-344 (1978).
`
`91. DAVIS, S.S. and BUBB, M.D. "Physicochemical studies on aerosol solutions for drug delivery.
`III. The effect of relative humidity on the particle size of inhalation aerosols". Int. J.
`Pharmaceut. 1 303-314 (1978).
`
`92. ASLAM, M., DAVIS, S.S. and FLETCHER, R.F. "Compliance in medication by Asian
`immigrants. Preliminary studies and the effect of counselling". Nursing Times 75 931-932
`(1979).
`
`93. TOMLINSON, E., DAVIS, S.S. and MUKHAYER, G.I. "Ionic interaction and phase stability".
`In Solution Chemistry of Surfactants, Vol. 1, p3-43, Editor K.L. Mittal, Plenum Press, New
`York (1979).
`
`94. TOMLINSON, E., GUVELI, D.E., DAVIS, S.S. and KAYES, J.B. "Anomalous behaviour of
`aromatic alcohols on the critical micelle concentrations of cationic agents". In Solution
`Chemistry of Surfactants, Vol. 1, p355-366, Editor K.L. Mittal, Plenum Press, New York
`(1979).
`
`95. TOMLINSON, E., DAVIS, S.S. and BROWN, J.E. "Effect of large ion complexation on the
`aqueous stability of acetyl-cholinesterases". In Solution Chemistry of Surfactants, Vol. 2,
`p867-878, Editor K.L. Mittal, Plenum Press, New York (1979).
`
`96. TOMLINSON, E., DAVIS, S.S. and MUKHAYER, G.I. "The interaction of phenothiazines with
`alkyl sulfates". In Solution Chemistry of Surfactants, Vol. 2, p880-902, Editor K.L. Mittal,
`Plenum Press, New York (1979).
`
`97. KERTES, A.S. and DAVIS, S.S. "Intellectual and Scholarly Judgement in Critical Evaluation of
`Numerical Data. A Case History". Proceedings of the 6th International CODATA Conference,
`p189-196, Pergamon Press, Oxford, 1979.
`
`98. DAVIS, S.S. "The role of Schools of Pharmacy". In Pharmaceutical Medicine, Editor, N.
`McCloud, p127-143, Churchill-Livingstone, London, 1979.
`
`99. MARRIOTT, C. and DAVIS, S.S. "A Frog in the Throat". Thorax 33 545-546 (1978).
`
`100. THURSTON, G.B. and DAVIS, S.S. "The viscoelastic properties of a soap stabilised
`oil-in-water emulsion". J. Colloid Interface Sci. 69 199-208 (1979).
`
`101. DAVIS, S.S., TOMLINSON, E. and WILSON, C.G. "On the transcorneal transport of drugs".
`Brit. J. Pharmacol. 64 444P (1978).
`
`102. DAVIS, S.S. "Formulations for the Future. Novel approaches to the design of drug dosage
`forms". In Pharmaceutical Medicine - The Future. Editors H. Lahon, R.K. Rondel and C.
`Kratochvil, p317-332, Acta Therapeutica, Brussels, 1979.
`
`103. GUVELI, D.E., KAYES, J.B. and DAVIS, S.S. "Hydrodynamic studies of micellar systems of
`alkyltrimethylammonium bromides and the effect of added 1-alkanols".
`
`13 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`J. Colloid Interface Sci. 72 130-139 (1979).
`
`104. DAVIS, S.S. and ASLAM, M. "Eastern Treatment for Eastern Health". J. Commun. Nurs. 2 16-20
`(1979).
`
`105. ASLAM, M. and DAVIS, S.S. "The practice of Asian medicine in the United Kingdom and the role
`of the visiting Hakim". Medicos 4 (2) (1979).
`
`106. ASLAM, M., DAVIS, S.S. and HEALY, M.A. "Heavy metals in some Asian medicines and
`cosmetics". Public Health 93 274-284 (1979).
`
`107. DAVIS, S.S. and KHANDERIA, M.S. "Rheological characteristics of Plastibases and the effect of
`formulation variables on the consistency of these vehicles. I. Continuous shear viscometry". Int. J.
`Pharm. Tech. & Prod. Manufact. 1 (2), 11-17 (1980).
`
`108. ROGERS, J.A. and DAVIS, S.S. "Functional group contributions to the partitioning of phenols
`between liposomes and water". Biochim. Biophys. Acta 598 392-404 (1980).
`
`109. TOMLINSON, E. and DAVIS, S.S. "Interactions between large organic ions of opposite and
`unequal charge. II. Ion pairing". J. Colloid Interface Sci. 74, 349-359 (1980).
`
`110. GREEN, S.D.R., LEALMAN, G.T., ASLAM, M. and DAVIS, S.S. "Surma and blood lead
`concentrations". Public Health 93 371-376 (1979).
`
`111. DAVIS, S.S. and KHANDERIA, M.S. "Rheological characterisation of Plastibases and the effect of
`formulation variables on the consistency of these vehicles. II. Small strain creep studies". Int. J.
`Pharm. Tech. & Prod. Dev. 1 (3) 15-21 (1980).
`
`112. DAVIS, S.S. "Prospects in pharmaceutical formulation". Int. J. Pharm. Tech. & Prod. Dev. 1 (3)
`7-13 (1980).
`
`14 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`113. DAVIS, S.S. and OLEJNIK, O. "An ion selective electrode for the determination of the activity
`of quaternary ammonium salts in formulated products".
`J. Pharm. Pharmac. 31 Suppl. 19P
`(1979).
`
`114. ROGERS, J.A., ANDERSON, N. and DAVIS, S.S. "The effect of functional groups on the
`energetics of partitioning of phenols between liposomes and water". J. Pharm. Pharmac. 31
`Suppl. 82P (1979).
`
`115. BURBAGE, A.S. and DAVIS, S.S. "Characterisation of multiple (w/o/w) emulsions using a
`radiotracer method". J. Pharm. Pharmac. 31 Suppl. 6P (1979).
`
`116. DAVIS, S.S. and HANSRANI, P. "The stabilisation of intravenous fat emulsions using
`phospholipids". J. Pharm. Pharmac. 31 Suppl. 2P (1979).
`
`117. DAVIS, S.S., PUREWAL, T.S. and ROUND, H.P. "Ostwald ripening in emulsion systems. The
`effect of an added third component". J. Pharm. Pharmac. 31 Suppl. 4P (1979).
`
`118. TOMLINSON, E. and DAVIS, S.S. "Interactions between large organic ions of opposite and
`unequal charge. III. Enthalpy-entropy linear compensation and application of solvophobic
`theory". J. Colloid Interface Sci. 76 568-572 (1980).
`
`Proc. Ciba-Geigy
`119. DAVIS, S.S. "Practical applications of viscoelasticity measurement".
`Symposium on Cough and Expectoration, Paris, 1979. Eur. J. Resp. Dis. 61 S110 141-156
`(1980).
`
`120. DAVIS, S.S., PUREWAL, T.S., CHOUDHURY, K., HANSRANI, P., WILSON, C.G.,
`HARDY, J.G. and FRIER, M. "Studies on the stability and in vivo deposition of intravenous
`emulsions". Proc. 2nd International Conference on Pharmaceutical Technology, Paris, Vol. V,
`189-197 (1980).
`
`121. ASLAM, M., HEALY, M.A., DAVIS, S.S. and ALI, A.R. "Surma and blood lead in children".
`Lancet, March 22nd, p685-659 (1980).
`
`122. DAVIS, S.S. "Colloids as drug delivery systems". Pharmaceutical Technology 5 71-88 (1981).
`
`123. WALKER, I.M., ASLAM, M. and DAVIS, S.S. "A comparative study of the use of a Pharmacy
`by the Asian and indigenous population of Bradford". Pharm. J. 225 703-705 (1980).
`
`124. DAVIS, S.S., ROUND, H.P. and PUREWAL, T.S. "Ostwald ripening of emulsions systems.
`An explanation for the effect of an added third component". J. Colloid Interface Sci. 80 508-511
`(1981).
`
`15 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`125. GUVELI, D.E., KAYES, J.B. and DAVIS, S.S. "Partial molal volume and light scattering studies
`on certain alkyltrimethylammonium bromides and the effect of added 1-alkanols". J. Colloid
`Interface Sci. 82 307-317 (1981).
`
`126. D'AMICO, K.M., DAVIS, S.S., FRIER, M., HANSRANI, P., HARDY, J.G. and WILSON, C.G.
`"Effects of emulsifiers on the elimination of intravenously administered fat emulsions measured by
`gamma scintigraphy". Brit. J. Pharmacol. 72 180P (1981).
`
`127. DAVIS, S.S. "Role of pharmaceutical sciences and disciplines in primary pharmaceutical
`education". In Pharmacy and Education, A Look Ahead into the 80's. Editors Brian, K.R. and
`Spencer, P.S.J., pp51-75, The University of Wales Institute of Science and Technology, 1980.
`
`128. MILLS, S.N., MAHER, S.E., DAVIS, S.S., HARDY, J.G. and WILSON, C.G. "The use of gamma
`scintigraphy for the in vivo assessment of colloidal dosage forms intended for parenteral use". J.
`Pharm. Pharmac. 32 Suppl. 85P (1980).
`
`129. DAVIS, S.S. and HANSRANI, P. "The influence of emulsifying agents on the phagocytosis of fat
`emulsions". J. Pharm. Pharmac. 32 Suppl. 61P (1980).
`
`130. PALIN, K., DAVIS, S.S., PHILLIPS, A.J., WHALLEY, D. and WILSON, C.G. "Effect of lipid
`vehicles on the oral absorption of a model compound (DDT)". J. Pharm. Pharmac. 32 Suppl. 62P
`(1980).
`
`131. AL-KHAMIS, K., DAVIS, S.S., HADGRAFT, J. and MILLS, S.N. "The determination of
`thermodynamic activity by gas chromatography head space analysis and its use in studying release
`rates of drugs from topical preparations". Int. J. Pharmaceut. 10 25-28 (1982).
`
`132. DAVIS, S.S. "The hunt for the Heineken Factor". Pharmacy International, 2 41-45 (1981).
`
`133. GUVELI, D.E., DAVIS, S.S. and KAYES, J.B. "Partial molal volume and light scattering studies
`on certain polyoxyethylene monohexadecyl ethers, and the effect of added aromatic solutes". J.
`Colloid Interface Sci. 86 213-225 (1982).
`
`134. ASLAM, M. and DAVIS, S.S. "Heavy metal toxicity of some Asian medicines in the United
`Kingdom". J. Pharm. Pharmac. 32 Suppl. 83P (1980).
`
`135. WILSON, C.G., TOMLINSON, E., DAVIS, S.S. and OLEJNIK, O. "Altered ocular absorption and
`disposition of sodium cromoglycate upon ion pair formation and complex coacervate formation with
`dodecylbenzyldimethyl ammonium chloride". J. Pharm. Pharmac. 33 749-753 (1981).
`
`16 of 76
`
`Fresenius Ex. 2037
`Bass et al. v. Fresenius Kabi USA, IPR2016-00254
`
`

`
`136. DAVIS, S.S. a

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket